The research conducted at CDD includes design, discovery and development of therapeutics for various conditions affecting human health. These diverse conditions include cancer, neurological disorders, viral diseases etc. Along with a proven track record of success in developing compounds of medicinal interest (carbovir and abacavir), CDD has added more drug candidates to its growing repertoire.
Spotlight on Research
Alzheimer’s Disease Research
Profs Robert Vince and Swati More have developed a noninvasive imaging technique that tracks accumulation of the Alzheimer’s peptide, amyloid-β, in the eye.
ProteXidineTM: Anti-Aging & Skin Care
CDD has developed a patented technology that prevents undesirable skin damage by both boosting the proportion of key DNA repair enzymes in the skin and filtering out damaging UV rays.
Pre-Clinical Study for Cyanide Antidote
A faster acting and safer than existing options, an antidote for cyanide poisoning that works prophylactically to prevent or limit toxicity associated from exposure to cyanide has been developed.